The Recall Desk

FDA (Drugs) recall action 72629

Pine Pharmaceuticals, LLC recalled 4 products on 2016-01-27

The FDA (Drugs) publishes a recall like this one as 4 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 4 pages.

Products
4
Announced
2016-01-27
Critical
0
Units
—

Why these products were recalled

Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

The agency’s own wording, quoted from the enforcement report.

States named across these recalls

1–4 of 4

  • SevereFDA (Drugs)··2016-01-27

    Pine Pharmaceuticals Recalls Bevacizumab Syringes Due to Silicone Oil Particulates

    Pine Pharmaceuticals is recalling Bevacizumab syringes for intravitreal use because they contain silicone oil microdroplets.

    Product
    Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2016-01-27

    Pine Pharmaceuticals Recalls Bevacizumab Syringes Due to Silicone Oil Microdroplets

    Pine Pharmaceuticals is recalling specific lots of bevacizumab syringes for intravitreal use due to the presence of silicone oil microdroplets.

    Product
    Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2016-01-27

    Pine Pharmaceuticals Recalls Bevacizumab Syringes Due to Silicone Oil Particulates

    Pine Pharmaceuticals is recalling specific lots of bevacizumab syringes for intravitreal injection because they contain silicone oil microdroplets.

    Product
    Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
    Category
    Distribution
    1 state
  • HighFDA (Drugs)··2016-01-27

    Pine Pharmaceuticals Recalls Bevacizumab Syringes Due to Silicone Oil Microdroplets

    Pine Pharmaceuticals is recalling specific lots of Bevacizumab syringes for intravitreal use because they contain silicone oil microdroplets.

    Product
    Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
    Category
    Distribution
    1 state